Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Scharf

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Hamostaseologie|February 11, 2016
Platelet pathology and antiplatelet strategies. Resolved and unresolved issuesR E Scharf
Hamostaseologie|November 7, 2003
[Congenital and acquired platelet function disorders]R E Scharf
Deutsche Medizinische Wochenschrift (1946)|April 7, 2011
[Do genetic factors reduce the effects of clopidogrel?]R E Scharf
Thrombosis and Haemostasis|August 13, 1990
In vitro thromboxane synthesis of depleted blood platelets following renal transplantationR E Scharf
Hamostaseologie|January 10, 2009
[Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management]R E Scharf
Deutsche Medizinische Wochenschrift (1946)|November 19, 2011
[Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?]R E Scharf
Fortschritte Der Neurologie-Psychiatrie|March 12, 2011
[Hemostatic disorders: clinical management based on molecular mechanisms]R E Scharf
Hamostaseologie|November 7, 2003
[Congenital and acquired thrombocytopenias]R E Scharf
Hamostaseologie|November 5, 2015
Coagulation disorders - recent lessons from clinical conditionsR E Scharf
Hamostaseologie|November 3, 2009
Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented interventionR E Scharf
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Hamostaseologie|February 11, 2016
Platelet pathology and antiplatelet strategies. Resolved and unresolved issuesR E Scharf
Hamostaseologie|November 7, 2003
[Congenital and acquired platelet function disorders]R E Scharf
Deutsche Medizinische Wochenschrift (1946)|April 7, 2011
[Do genetic factors reduce the effects of clopidogrel?]R E Scharf
Thrombosis and Haemostasis|August 13, 1990
In vitro thromboxane synthesis of depleted blood platelets following renal transplantationR E Scharf
Hamostaseologie|January 10, 2009
[Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management]R E Scharf
Deutsche Medizinische Wochenschrift (1946)|November 19, 2011
[Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?]R E Scharf
Fortschritte Der Neurologie-Psychiatrie|March 12, 2011
[Hemostatic disorders: clinical management based on molecular mechanisms]R E Scharf
Hamostaseologie|November 7, 2003
[Congenital and acquired thrombocytopenias]R E Scharf
Hamostaseologie|November 5, 2015
Coagulation disorders - recent lessons from clinical conditionsR E Scharf
Hamostaseologie|November 3, 2009
Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented interventionR E Scharf
Pageof 9